4Chan DL, Alzahrani NA, Morris DL, et al. Systematic review and meta-analysis of hepatic arterial infusion chemotherapy as bridging therapy for colorectal liver metastases. Surg Oncol, 2015,24 ( 3 ) : 162 - 171.
5Shi L, Zhao J, Lu Q, et al. Initial hepatic artery infusion and systemic chemotherapy for asymptomatic colorectal cancer with un-resectable liver metastasis. Int J Clin Exp Med,2015,8( 1 ) :1000 - 1008.
6Alberts SR, Roh MS, Maboney MR, et al. Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) phase lI intergroup trial, N9945/CI-66. J Clin Oncol, 2010,28(5) :853 -858.
7Prigerson HG, Bao Y, Shah MA, et al. Chemotherapy use, performance status, and quality of llfe at the end of life. JAMA Oncol,2015,1 (6) :778 -784.
8孙燕,主编.内科肿瘤学.第1版.北京:人民卫生出版社,2007.995-996.
9Allard MA, Malka D. Place of hepatic intra-arterial chemotherapy in the treatment of eoloreetal liver metastases. J Vise Surg,2014,151 (1):21 -24.
10Moeellin S, Pasquali S, Nitti D. Fluoropyrimidine-HAI ( hepaticarterial infusion) versus systemic chemotherapy ( SCT ) for unreseetable liver metastases from eolorectal cancer. Cochrane Database Syst Rev,2009,8 (3) : CD007823.
